Did National Security Imperatives Compromise COVID-19 Vaccine Safety?
The US Department of Defense (US DoD) has had a dominant role in the response to the SARS-CoV-2 virus and in the development, and distribution of the Covid 19 vaccines, a fact hidden from the general public. In those processes many standard steps and procedures, otherwise required for pharmaceutical products, were omitted or circumvented.
We now know they do not prevent infection nor transmission and have not prevented a continuing high incidence of COVID-19. Furthermore they are associated with an unprecedented incidence of serious adverse events and deaths compared to any other drugs in the history of the pharmaceutical industry.
We are probably facing the worst health disaster in history.
How did the pharmaceutical industry, our governments and our drug regulators get it so wrong? A plausible answer to this question has emerged within the last few weeks.
Contrary to popular belief that pharmaceutical companies drove the COVID vaccine development programs, the US FDA’s website (FDA, 2020) reveals that the United States Department of Defence (DoD) has been in full control of the Covid Vaccine development program since its beginning.
The DoD has been responsible for development, manufacturing, clinical trials, quality assurance, distribution and administration, since that time. The Chief Operating Officer for the Warp Speed vaccine program is the US Department of Defence, and the Chief Science Advisor is the US Department of Health and Human Services (HHS).
In addition to Phillip M. Altman BPharm(Hons) MSc PhD, coauthors on this piece include James Rowe BPharm, MSc, PhD FRSN, Wendy Hoy AO FAA FRACP, Gerry Brady MBBS, Astrid Lefringhausen, PhD, Robyn Cosford MBBS(Hons) FACNEM FASLM, and Bruce Wauchope MBBS – DTM&H, Dip OBS RACOG, FRACGP.